VOGLISTAR MD 0.2 TABLET is used in the management of type 2 diabetes mellitus along with diet and exercise to improve post-prandial blood glucose levels (when only diet and/or exercise or oral hypoglycemic drugs or insulin preparation in addition to diet and/or exercise does not result in adequate glycemic control). It contains
Voglibose
which belongs to the group of medicines called Anti-diabetics. It works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This manages the level of blood glucose from increasing very high immediately after meals.
Along management with VOGLISTAR MD 0.2 TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. VOGLISTAR MD 0.2 TABLET is not recommended for use in patients having severe ketosis, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.
VOGLISTAR MD 0.2 TABLET should be used with caution in patients undergoing abdominal laparotomy for gallstone ileus or have roemheld’s syndrome, stenosis, liver, and kidney problems and in elderly patients. VOGLISTAR MD 0.2 TABLET is not recommended for use among pregnant, breastfeeding women, children, and adolescents. The most common side effects of taking VOGLISTAR MD 0.2 TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your doctor if any of the above symptoms worsen.
No content available
